Skip to main content
Premium Trial:

Request an Annual Quote

DoubleTwist Signs Host of New Subscribers in Q2

NEW YORK, July 11 – DoubleTwist of Oakland, Calif., said Wednesday that in the second quarter of 2001 it had signed more than 10 new subscribers to its genomic data and analysis tools available through DoubleTwist.com.

The news comes on the heels of a similar announcement made in April in which DoubleTwist said that it had signed 20 new subscribers in the first quarter of the year.

DoubleTwist did not comment on the subscription fees the new users were paying and a spokesperson was not immediately available for comment.

The spate of good news seems to mark a turnaround for the company, which was forced to cancel its IPO due to poor market conditions. Later, DoubleTwist cut its staff, triggering questions about whether or not the company would survive.

The new customers include Cedars Sinai Medical Center, DeveloGen, Icagen, Laboratoires Fournier, MD Anderson Cancer Center, The National Cancer Institute, Organon, Oxagen, Pherin Pharmaceuticals, Provalis, Switch Biotech, The University of California at Davis, The University of Reading, The Weizmann Institute of Science, and a number of unnamed organizations in Europe and Asia.
 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.